Results 41 to 50 of about 400,631 (298)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

open access: yesJournal of Intensive Care, 2022
Background Levetiracetam pharmacokinetics is extensively altered in critically ill patients with augmented renal clearance (ARC). Consequently, the dosage regimens commonly used in clinical practice may not be sufficient to achieve target plasma ...
Idoia Bilbao-Meseguer   +7 more
doaj   +1 more source

Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease

open access: yesNanomaterials, 2022
Gene supplementation therapy with plasmid DNA (pDNA) represents one of the most promising strategies for the treatment of monogenic diseases such as Fabry disease (FD).
Julen Rodríguez-Castejón   +5 more
doaj   +1 more source

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

open access: yesFrontiers in Oncology, 2023
IntroductionAlterations in expression and activity of human receptor tyrosine kinases (RTKs) are associated with cancer progression and in response to therapeutic intervention.MethodsThus, protein abundance of 21 RTKs was assessed in 15 healthy and 18 ...
Areti-Maria Vasilogianni   +8 more
doaj   +1 more source

Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development

open access: yesFrontiers in Immunology
The clinical immunogenicity assessment for complex multidomain biological drugs is challenging due to multiple factors that must be taken into consideration.
Charlotte Hagman   +7 more
doaj   +1 more source

Building in-house PBPK modelling tools for oral drug administration from literature information

open access: yesADMET and DMPK, 2019
The interest in using physiologically-based pharmacokinetic (PBPK) models as a support to the drug development decision making process has rapidly increased in the last years. These kind of models are examples of the “bottom up” modelling strategy, which
Silvia Grandoni   +4 more
doaj   +1 more source

Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2015
OBJECTIVES: This study aimed to systematically review and quantitatively synthesize the association between HLA-B*5701 and abacavir-induced hypersensitivity reaction (ABC-HSR).
Wimonchat Tangamornsuksan   +6 more
doaj   +1 more source

Pharmacokinetic parameters.

open access: yes, 2022
Pharmacokinetic parameters.
Paul Korner (5243786)   +5 more
core   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

QSAR-based physiologically based pharmacokinetic (PBPK) modeling for 34 fentanyl analogs: model validation, human pharmacokinetic prediction and abuse risk insights

open access: yesFrontiers in Pharmacology
IntroductionFentanyl analogs, as emerging new psychoactive substances (NPS), pose a global public health threat due to widespread abuse, high toxicity, and frequent overdose fatalities.
Simeng Zhang   +19 more
doaj   +1 more source

Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn’s Disease Patients through PBPK Modeling

open access: yesPharmaceutics, 2023
The most common method for establishing bioequivalence (BE) is to demonstrate similarity of concentration–time profiles in the systemic circulation, as a surrogate to the site of action.
Chunyan Han   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy